Immune functional assays, from custom to standardized tests for precision medicine

Frontiers in Immunology

Volumn 9, Issue OCT, 2018, Pages

  Albert Vega, Chloé ^a   Tawfik, Dina M ^b,c   Trouillet Assant, Sophie ^a,d   Vachot, Laurence ^b   Mallet, François ^a,c   Textoris, Julien ^c,e  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b BIOMÉRIEUX   (France)

^c University of Lyon EA 7426 Pathophysiology of Injury Induced Immunosuppression PI3   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

Critically ill patients; Host response; IGRA; Immune functional assay; Immune monitoring; Immunoprofiling; Sepsis; Stimulation

Indexed keywords

FUNCTIONAL ASSESSMENT; HUMAN; IMMUNE FUNCTIONAL ASSAY; IMMUNOASSAY; IMMUNOLOGICAL MONITORING; INFECTION; NONHUMAN; PERSONALIZED MEDICINE; REVIEW; STANDARDIZATION; ANIMAL; DISEASE MANAGEMENT; DISEASE PREDISPOSITION; PROCEDURES;

ANIMALS; DISEASE MANAGEMENT; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOASSAY; PRECISION MEDICINE;

EID: 85055349308     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2018.02367     Document Type: Review

References (84)

1. Murphy K, Weaver C. The Immune System in Health and Disease. In: Janeway's Immunobiology, 9th Edn. Kenneth M, Casey W, editors. New York, NY: Garland Science Taylor & Francis Group (2017), p. 533-748.
2. Singer M, Deutschman CS, Seymour C, Shankar-Hari M, Annane D, Bauer M, et al. (2016). The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801-810. doi: 10.1001/jama.2016.0287 CrossRef Full Text | Google Scholar
3. Lindemann M. Ex vivo assessment of cellular immune function - applications in patient care and clinical studies. Tissue Antigens (2014) 84:439-49. doi: 10.1111/tan.12454 PubMed Abstract | CrossRef Full Text | Google Scholar
4. Rusnock AA. Historical context and the roots of Jenner's discovery. Hum Vacc Immunother. (2016) 12:2025-8. doi: 10.1080/21645515.2016.1158369 PubMed Abstract | CrossRef Full Text | Google Scholar
5. Blevins SM, Bronze MS. Robert Koch and the 'golden age' of bacteriology. Int J Infect Dis. (2010) 14:e744-e751. doi: 10.1016/j.ijid.2009.12.003 PubMed Abstract | CrossRef Full Text | Google Scholar
6. McCusker C, Warrington R. Primary immunodeficiency. Allergy Asthma Clin Immunol. (2011) 7(Suppl. 1):S11-S11. doi: 10.1186/1710-1492-7-S1-S11 PubMed Abstract | CrossRef Full Text | Google Scholar
7. Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infect Dis Rep. (2016) 8:6570. doi: 10.4081/idr.2016.6570 PubMed Abstract | CrossRef Full Text | Google Scholar
8. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific Detection of Tuberculosis Infection. Am J Respir Crit Care Med. (2004) 170:59-64. doi: 10.1164/rccm.200402-179OC PubMed Abstract | CrossRef Full Text | Google Scholar
9. Lindeboom JA, Kuijper EJ, Prins JM, Bruijnesteijn van Coppenraet ES, Lindeboom R. Tuberculin skin testing is useful in the screening for nontuberculous Mycobacterial Cervicofacial Lymphadenitis in children. Clin Infect Dis. (2006) 43:1547-51. doi: 10.1086/509326 PubMed Abstract | CrossRef Full Text | Google Scholar
10. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet (2000) 356:1099-104. doi: 10.1016/S0140-6736(00)02742-2 PubMed Abstract | CrossRef Full Text | Google Scholar
11. Ariga H, Harada N. Evolution of IGRA researches. Kekkaku (2008) 83:641-52. PubMed Abstract | Google Scholar
12. Roy A, Eisenhut M, Harris RJ, Rodrigues LC, Sridhar S, Habermann S, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis. BMJ (2014) 349:g4643. doi: 10.1136/bmj.g4643 PubMed Abstract | CrossRef Full Text | Google Scholar
13. Pai M, Rodrigues C. Management of latent tuberculosis infection: an evidence-based approach. Lung India (2015) 32:205-7. doi: 10.4103/0970-2113.156210 PubMed Abstract | CrossRef Full Text | Google Scholar
14. Corbière V, Pottier G, Bonkain F, Schepers K, Verscheure V, Lecher S, et al. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. PLoS ONE (2012) 7:e43285. doi: 10.1371/journal.pone.0043285 PubMed Abstract | CrossRef Full Text | Google Scholar
15. Millan O, Brunet M. Cytokine-based immune monitoring. Clin Biochem (2016) 49:338-46. doi: 10.1016/j.clinbiochem.2016.01.004 PubMed Abstract | CrossRef Full Text | Google Scholar
16. Han SH. Immunological prediction of cytomegalovirus (CMV) replication risk in solid organ transplantation recipients: approaches for regulating the targeted anti-CMV prevention strategies. Infect Chemother. (2017) 49:161-175. doi: 10.3947/ic.2017.49.3.161 PubMed Abstract | CrossRef Full Text | Google Scholar
17. Bousfiha A, Jeddane L, Al-Herz W, Ailal F, Casanova JL, Chatila T, et al. The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol. (2015) 35:727-38. doi: 10.1007/s10875-015-0198-5 PubMed Abstract | CrossRef Full Text | Google Scholar
18. Condino-Neto A, Espinosa-Rosales FJ. Changing the lives of people with primary immunodeficiencies (PI) with early testing and diagnosis. Front Immunol. (2018) 9:1439. doi: 10.3389/fimmu.2018.01439 PubMed Abstract | CrossRef Full Text | Google Scholar
19. Lindegren ML, Kobrynski L, Rasmussen SA, Moore CA, Grosse SD, Vanderford ML, et al. Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep. (2004) 53:1-29. PubMed Abstract | Google Scholar
20. de Vries E European Society for Immunodeficiencies m Patient-centred screening for primary immunodeficiency a multi-stage diagnostic protocol designed for non-immunologists: 2011 update. Clin Exp Immunol. (2012) 167:108-119. doi: 10.1111/j.1365-2249.2011.04461.x CrossRef Full Text | Google Scholar
21. Notarangelo LD. Functional T Cell Immunodeficiencies (with T Cells Present). Ann Rev Immunol. (2013) 31:195-225. doi: 10.1146/annurev-immunol-032712-095927 PubMed Abstract | CrossRef Full Text | Google Scholar
22. Poujol F, Monneret G, Friggeri A, Rimmelé T, Malcus C, Poitevin-Later F, et al. Flow cytometric evaluation of lymphocyte transformation test based on 5-ethynyl-2'deoxyuridine incorporation as a clinical alternative to tritiated thymidine uptake measurement. J Immunol Methods (2014) 415:71-79. doi: 10.1016/j.jim.2014.10.006 PubMed Abstract | CrossRef Full Text | Google Scholar
23. Abraham RS. Relevance of laboratory testing for the diagnosis of primary immunodeficiencies: a review of case-based examples of selected immunodeficiencies. Clin Mol Allergy (2011) 9:6. doi: 10.1186/1476-7961-9-6 PubMed Abstract | CrossRef Full Text | Google Scholar
24. Gupta M, Cox A, Nowak-Wegrzyn A, Wang J. Diagnosis of Food Allergy. Immunol Allergy Clin North Am. (2018) 38:39-52. doi: 10.1016/j.iac.2017.09.004 PubMed Abstract | CrossRef Full Text | Google Scholar
25. Heinzerling L, Mari A, Bergmann K-C, Bresciani M, Burbach G, Darsow U, et al. The skin prick test - European standards. Clin Transl Allergy (2013) 3:3-3. doi: 10.1186/2045-7022-3-3 PubMed Abstract | CrossRef Full Text | Google Scholar
26. Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy (2015) 70:1393-405. doi: 10.1111/all.12698 PubMed Abstract | CrossRef Full Text | Google Scholar
27. Sindhi R, Ashokkumar C, Higgs BW, Levy S, Soltys K, Bond G, et al. Profile of the Pleximmune blood test for transplant rejection risk prediction. Expert Rev Mol Diagnost. (2016) 16:387-93. doi: 10.1586/14737159.2016.1139455 PubMed Abstract | CrossRef Full Text | Google Scholar
28. Distler E, Schnürer E, Wagner E, von Auer C, Plachter B, Wehler D, et al. Recovery of varicella-zoster virus specific T cell immunity after T cell depleted allogeneic transplantation requires symptomatic virus reactivation. Biol Blood Marrow Transpl. (2008) 14:1417-24. doi: 10.1016/j.bbmt.2008.09.004 PubMed Abstract | CrossRef Full Text | Google Scholar
29. Hoshina T, Ohga S, Fujiyoshi J, Nanishi E, Takimoto T, Kanno S, et al. Memory B-cell pools predict the immune response to pneumococcal conjugate vaccine in immunocompromised children. J Infect Dis. (2016) 213:848-55. doi: 10.1093/infdis/jiv469 PubMed Abstract | CrossRef Full Text | Google Scholar
30. Fleischmann C, Scherag A, Adhikari NKJ, Hartog CS, Tsaganos T, Schlattmann P, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Curr Estimates Limit Am J Respir Crit Care Med. (2015) 193:259-72. doi: 10.1164/rccm.201504-0781OC PubMed Abstract | CrossRef Full Text | Google Scholar
31. Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA (2018) 319:62-75. doi: 10.1001/jama.2017.17687 PubMed Abstract | CrossRef Full Text | Google Scholar
32. van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. (2017) 17:407. doi: 10.1038/nri.2017.36 PubMed Abstract | CrossRef Full Text | Google Scholar
33. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. (2013) 13:862-74. doi: 10.1038/nri3552 PubMed Abstract | CrossRef Full Text | Google Scholar
34. Sweeney TE, Wong HR. Risk stratification and prognosis in sepsis: what have we learned from microarrays? Clin Chest Med. (2016) 37:209-18. doi: 10.1016/j.ccm.2016.01.003 PubMed Abstract | CrossRef Full Text | Google Scholar
35. Rimmelé T, Payen D, Cantaluppi V, Marshall J, Gomez H, Gomez A, et al. Immune cell phenotype and function in sepsis. Shock (2016) 45:282-91. doi: 10.1097/SHK.0000000000000495 PubMed Abstract | CrossRef Full Text | Google Scholar
36. Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. (2012) 25:609-34. doi: 10.1128/cmr.00016-12 PubMed Abstract | CrossRef Full Text | Google Scholar
37. Caironi P, Masson S, Mauri T, Bottazzi B, Leone R, Magnoli M, et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. Eur J Clin Invest. (2017) 47:73-83. doi: 10.1111/eci.12704 CrossRef Full Text | Google Scholar
38. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA (2011) 306:2594-605. doi: 10.1001/jama.2011.1829 PubMed Abstract | CrossRef Full Text | Google Scholar
39. Monneret G, Venet F. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytometry Part B (2016) 90:376-86. doi: 10.1002/cyto.b.21270 PubMed Abstract | CrossRef Full Text | Google Scholar
40. Venet F, Lukaszewicz AC, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. (2013) 25:477-83. doi: 10.1016/j.coi.2013.05.006 PubMed Abstract | CrossRef Full Text | Google Scholar
41. Conway Morris A, Anderson N, Brittan M, Wilkinson TS, McAuley DF, Antonelli J, et al. Combined dysfunctions of immune cells predict nosocomial infection in critically ill patients. Br J Anaesth (2013) 111:778-87. doi: 10.1093/bja/aet205 CrossRef Full Text | Google Scholar
42. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. (2009) 180:640-8. doi: 10.1164/rccm.200903-0363OC PubMed Abstract | CrossRef Full Text | Google Scholar
43. Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, et al. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight (2018) 3:5. doi: 10.1172/jci.insight.98960 PubMed Abstract | CrossRef Full Text | Google Scholar
44. Cavaillon J-M, Adib-Conquy M. Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Critical Care (2006) 10:233-3. doi: 10.1186/cc5055 PubMed Abstract | CrossRef Full Text | Google Scholar
45. Holz O, Tan L, Schaumann F, Muller M, Scholl D, Hidi R, et al. Inter- and intrasubject variability of the inflammatory response to segmental endotoxin challenge in healthy volunteers. Pulm Pharmacol Ther. (2015) 35:50-9. doi: 10.1016/j.pupt.2015.10.011 PubMed Abstract | CrossRef Full Text | Google Scholar
46. Fitting C, Dhawan S, Cavaillon J-M. Compartmentalization of Tolerance to Endotoxin. J Infect Dis. (2004) 189:1295-303. doi: 10.1086/382657 PubMed Abstract | CrossRef Full Text | Google Scholar
47. Demaret J, Venet F, Friggeri A, Cazalis MA, Plassais J, Jallades L, et al. Marked alterations of neutrophil functions during sepsis-induced immunosuppression. J Leukoc Biol. (2015) 98:1081-90. doi: 10.1189/jlb.4A0415-168RR PubMed Abstract | CrossRef Full Text | Google Scholar
48. Pfortmueller CA, Meisel C, Fux M, Schefold JC. Assessment of immune organ dysfunction in critical illness: utility of innate immune response markers. Intensive Care Med Exp. (2017) 5:49. doi: 10.1186/s40635-017-0163-0 PubMed Abstract | CrossRef Full Text | Google Scholar
49. Morris AC, Brittan M, Wilkinson TS, McAuley DF, Antonelli J, McCulloch C, et al. C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood (2011) 117:5178-88. doi: 10.1182/blood-2010-08-304667 PubMed Abstract | CrossRef Full Text | Google Scholar
50. Morton B, Mitsi E, Pennington SH, Reine J, Wright AD, Parker R, et al. Augmented Passive immunotherapy with p4 peptide improves phagocyte activity in severe sepsis. Shock (2016) 46:635-41. doi: 10.1097/shk.0000000000000715 PubMed Abstract | CrossRef Full Text | Google Scholar
51. Pinder EM, Rostron AJ, Hellyer TP, Ruchaud-Sparagano MH, Scott J, Macfarlane JG, et al. Randomised controlled trial of GM-CSF in critically ill patients with impaired neutrophil phagocytosis. Thorax (2018). doi: 10.1136/thoraxjnl-2017-211323 PubMed Abstract | CrossRef Full Text | Google Scholar
52. Antonakos N, Tsaganos T, Oberle V, Tsangaris I, Lada M, Pistiki A, et al. Decreased cytokine production by mononuclear cells after severe gram-negative infections: early clinical signs and association with final outcome. Critical Care (2017) 21:48. doi: 10.1186/s13054-017-1625-1 PubMed Abstract | CrossRef Full Text | Google Scholar
53. MonneretG, Demaret J, Gossez M, Reverdiau E, Malergue F, Rimmelé T, et al. Novel approach in monocyte intracellular TNF measurement: application to sepsis-induced immune alterations. Shock (2017) 47:318-22. doi: 10.1097/shk.0000000000000724 PubMed Abstract | CrossRef Full Text | Google Scholar
54. Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. (2016) 4:259-71. doi: 10.1016/s2213-2600(16)00046-1 PubMed Abstract | CrossRef Full Text | Google Scholar
55. Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. (2017a) 5:816-26. doi: 10.1016/s2213-2600(17)30294-1 PubMed Abstract | CrossRef Full Text | Google Scholar
56. Sweeney TE, Perumal TM, Henao R, Nichols M, Howrylak JA, Choi AM, et al. A community approach to mortality prediction in sepsis via gene expression analysis. Nat Commun. (2018) 9:694. doi: 10.1038/s41467-018-03078-2 PubMed Abstract | CrossRef Full Text | Google Scholar
57. Li Y, Oosting M, Deelen P, Ricano-Ponce I, Smeekens S, Jaeger M, et al. Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi. Nat Med. (2016) 22:952-60. doi: 10.1038/nm.4139 CrossRef Full Text | Google Scholar
58. Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell (2016) 167:1125-36.e1128. doi: 10.1016/j.cell.2016.10.020 CrossRef Full Text | Google Scholar
59. Ter Horst R, Jaeger M, Smeekens SP, Oosting M, Swertz MA, Li Y, et al. Host and environmental factors influencing individual human cytokine responses. Cell (2016) 167:1111-24.e1113. doi: 10.1016/j.cell.2016.10.018 PubMed Abstract | CrossRef Full Text | Google Scholar
60. Pera A, Campos C, López N, Hassouneh F, Alonso C, Tarazona R, et al. Immunosenescence: implications for response to infection and vaccination in older people. Maturitas (2015) 82:50-5. doi: 10.1016/j.maturitas.2015.05.004 PubMed Abstract | CrossRef Full Text | Google Scholar
61. Iliodromiti Z, Anastasiadis A, Varras M, Pappa KI, Siristatidis C, Bakoulas V, et al. Monocyte function in the fetus and the preterm neonate: immaturity combined with functional impairment. Mediators Inflammat. (2013) 2013:753752. doi: 10.1155/2013/753752 PubMed Abstract | CrossRef Full Text | Google Scholar
62. Arts RJW, Moorlag SJCFM, Novakovic B, Li Y, Wang SY, Oosting M, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe (2018) 23:89-100.e105. doi: 10.1016/j.chom.2017.12.010 PubMed Abstract | CrossRef Full Text | Google Scholar
63. Campos M, Godson DL. The effectiveness and limitations of immune memory: understanding protective immune responses. Int J Parasitol. (2003) 33:655-61. doi: 10.1016/S0020-7519(03)00066-3 PubMed Abstract | CrossRef Full Text | Google Scholar
64. Piasecka B, Duffy D, Urrutia A, Quach H, Patin E, Posseme C, et al. Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges. Proc Natl Acad Sci. (2018) 115:E488-497. doi: 10.1073/pnas.1714765115 PubMed Abstract | CrossRef Full Text | Google Scholar
65. Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell (2014) 157:121-41. doi: 10.1016/j.cell.2014.03.011 PubMed Abstract | CrossRef Full Text | Google Scholar
66. Wang B, Yao M, Lv L, Ling Z, Li L. The human microbiota in health and disease. Engineering (2017) 3:71-82. doi: 10.1016/J.ENG.2017.01.008 CrossRef Full Text | Google Scholar
67. Lankelma JM, van Vught LA, Belzer C, Schultz MJ, van der Poll T, de Vos WM, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med. (2017) 43:59-68. doi: 10.1007/s00134-016-4613-z CrossRef Full Text | Google Scholar
68. Dona I, Torres MJ, Montanez MI, Fernandez TD. In vitro diagnostic testing for antibiotic allergy. Allergy Asthma Immunol Res. (2017) 9:288-98. doi: 10.4168/aair.2017.9.4.288 PubMed Abstract | CrossRef Full Text
69. Moylett EH, Wasan AN, Noroski LM, Shearer WT. Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol. (2004) 112:106-12. doi: 10.1016/j.clim.2004.02.008 PubMed Abstract | CrossRef Full Text | Google Scholar
70. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P. Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol. (2000) 7:155-60. doi: 10.1128/CDLI.7.2.155-160.2000 PubMed Abstract | CrossRef Full Text | Google Scholar
71. Dietsch GN, Randall TD, Gottardo R, Northfelt DW, Ramanathan RK, Cohen PA, et al. Late-stage cancer patients remain highly responsive to immune activation by the selective TLR8 agonist motolimod (VTX-2337). Clin Cancer Res. (2015) 21:5445-52. doi: 10.1158/1078-0432.ccr-15-0578 PubMed Abstract | CrossRef Full Text | Google Scholar
72. Mir Viladrich I, Dauden Tello E, Solano-Lopez G, Lopez Longo FJ, Taxonera Samso C, Sanchez Martinez P, et al. Consensus document on prevention and treatment of tuberculosis in patients for biological treatment. Arch Bronconeumol. (2016) 52:36-45. doi: 10.1016/j.arbres.2015.04.016 PubMed Abstract | CrossRef Full Text | Google Scholar
73. Neuvonen P, Salo M, Viljanen M, Helander I. Delayed hypersensitivity skin testing of 150 volunteers. Allergy (1985) 40:208-12. doi: 10.1111/j.1398-9995.1985.tb00218.x PubMed Abstract | CrossRef Full Text | Google Scholar
74. Pottumarthy S, Morris AJ, Harrison AC, Wells VC. Evaluation of the tuberculin gamma interferon assay: potential to replace the mantoux skin test. J Clin Microbiol. (1999) 37:3229-32. PubMed Abstract | Google Scholar
75. Ulrichs T, Munk ME, Mollenkopf H, Behr-Perst S, Colangeli R, Gennaro ML, et al. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol. (1998) 28:3949-58. doi: 10.1002/(SICI)1521-4141(199812)28:123949::AID-IMMU39493.0.CO;2-4 PubMed Abstract | CrossRef Full Text | Google Scholar
76. Urrutia A, Duffy D, Rouilly V, Posseme C, Djebali R, Illanes G, et al. Standardized whole-blood transcriptional profiling enables the deconvolution of complex induced immune responses. Cell Rep. (2016) 16:2777-91. doi: 10.1016/j.celrep.2016.08.011 PubMed Abstract | CrossRef Full Text | Google Scholar
77. Duffy D, Rouilly V, Braudeau C, Corbière V, Djebali R, Ungeheuer M-N, et al. Standardized whole blood stimulation improves immunomonitoring of induced immune responses in multi-center study. Clin. Immunol. (2017) 183:325-35. doi: 10.1016/j.clim.2017.09.019 PubMed Abstract | CrossRef Full Text | Google Scholar
78. Mathiak G, Kabir K, Grass G, Keller H, Steinringer E, Minor T, et al. Lipopolysaccharides from different bacterial sources elicit disparate cytokine responses in whole blood assays. Int J Mol Med. (2003) 11:41-4. doi: 10.3892/ijmm.11.1.41 PubMed Abstract | CrossRef Full Text | Google Scholar
79. Gutschow MV, Hughey JJ, Ruggero NA, Bajar BT, Valle SD, Covert MW. Single-cell and population NF-κB dynamic responses depend on lipopolysaccharide preparation. PLoS ONE (2013) 8:e53222. doi: 10.1371/journal.pone.0053222 PubMed Abstract | CrossRef Full Text | Google Scholar
80. Arens C, Bajwa SA, Koch C, Siegler BH, Schneck E, Hecker A, et al. Sepsis-induced long-term immune paralysis - results of a descriptive, explorative study. Critical Care (2016) 20:93. doi: 10.1186/s13054-016-1233-5 PubMed Abstract | CrossRef Full Text | Google Scholar
81. Shankar-Hari M, Summers C, Baillie K. In pursuit of precision medicine in the critically ill. In: Vincent JL, editors. Annual Update in Intensive Care and Emergency Medicine. Cham: Springer (2018) 649-58. doi: 10.1007/978-3-319-73670-9-48 CrossRef Full Text | Google Scholar
82. Conway Morris A, Datta D, Shankar-Hari M, Stephen J, Weir CJ, Rennie J, et al. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. (2018) 44:627-35. doi: 10.1007/s00134-018-5247-0 PubMed Abstract | CrossRef Full Text | Google Scholar
83. Rol ML, Venet F, Rimmele T, Moucadel V, CortezP, Quemeneur L, et al. The REAnimation low immune status markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients. BMJ Open (2017) 7: e015734. doi: 10.1136/bmjopen-2016-015734 PubMed Abstract | CrossRef Full Text | Google Scholar
84. Sweeney TE, Wong HR, Khatri P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med. (2016) 8:346ra391. doi: 10.1126/scitranslmed.aaf7165 PubMed Abstract | CrossRef Full Text | Google Scholar